The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families
Open accessAbstract
Context: An association between germline aryl hydrocarbon receptor-interacting protein (AIP) gene mutations and pituitary adenomas was recently shown. Objective: The objective of the study was to assess the frequency of AIP gene mutations in a large cohort of patients with familial isolated pituitary adenoma (FIPA). Design: This was a multicenter, international, collaborative study. Setting: The study was conducted in 34 university endocrinology and genetics departments in nine countries. Patients: Affected members from each FIPA family were studied. Relatives of patients with AIP mutations underwent AIP sequence analysis. Main Outcome Measures: Presence/absence and description of AIP gene mutations were the main outcome measures. Intervention: There was no intervention. Results: Seventy-three FIPA families were identified, with 156 patients with pituitary adenomas; the FIPA cohort was evenly divided between families with homogeneous and heterogeneous tumor expression. Eleven FIPA families had 10 germline AIP mutations. Nine mutations, R16H, G47_R54del, Q142X, E174frameshift, Q217X, Q239X, K241E, R271W, and Q285frameshift, have not been described previously. Tumors were significantly larger (P = 0.0005) and diagnosed at a younger age (P = 0.0006) in AIP mutation-positive vs. mutation-negative subjects. Somatotropinomas predominated among FIPA families with AIP mutations, but mixed GH/prolactin-secreting tumors, prolactinomas, and nonsecreting adenomas were also noted. Approximately 85% of the FIPA cohort and 50% of those with familial somatotropinomas were negative for AIP mutations. Conclusions: AIP mutations, of which nine new mutations have been described here, occur in approximately 15% of FIPA families. Although pituitary tumors occurring in association with AIP mutations are predominantly somatotropinomas, other tumor types are also seen. Further study of the impact of AIP mutations on protein expression and activity is necessary to elucidate their role in pituitary tumorigenesis in FIPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
The prevalence of pituitary adenomas: A systematic review
Ezzat, S., Asa, S. L., Couldwell, W. T., Barr, C. E., Dodge, W. E., Vance, M. L., & McCutcheon, I. E. (2004) · Cancer · doi:10.1002/cncr.20412 · Cited by 1,345
High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium
Daly, A. F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M. A., & Beckers, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1668 · Cited by 1,025
Self-citationPituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)
Pei, L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.433 · Cited by 576
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8145 · Cited by 483
Self-citationUse of population isolates for mapping complex traits
Peltonen, L., Palotie, A., & Lange, K. (2000) · Nature Reviews Genetics · doi:10.1038/35042049 · Cited by 455
The role of chaperone proteins in the aryl hydrocarbon receptor core complex
Petrulis, J. R., & Perdew, G. H. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00064-9 · Cited by 295
Meyer, B. K., & Perdew, G. H. (1999) · Biochemistry · doi:10.1021/bi982223w · Cited by 232
Characterization of the Ah Receptor-associated Protein, ARA9
Carver, L. A., LaPres, J. J., Jain, S., Dunham, E. E., & Bradfield, C. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33580 · Cited by 208
Binding of Aryl Hydrocarbon Receptor (AhR) to AhR-interacting Protein
Bell, D. R., & Poland, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004236200 · Cited by 180
Molecular Pathology of the MEN1 Gene
AGARWAL, S. K., LEE BURNS, A., SUKHODOLETS, K. E., KENNEDY, P. A., OBUNGU, V. H., HICKMAN, A. B., MULLENDORE, M. E., WHITTEN, I., SKARULIS, M. C., SIMONDS, W. F., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.020 · Cited by 163
Meyer, B. K., Petrulis, J. R., & Perdew, G. H. (2000) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2000)005<0243:aharla>2.0.co;2 · Cited by 108
Qian, Z. R., Sano, T., Asa, S. L., Yamada, S., Horiguchi, H., Tashiro, T., Li, C. C., Hirokawa, M., Kovács, K., & Ezzat, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031489 · Cited by 83
Aryl Hydrocarbon Receptor Interacting Protein Variants in Sporadic Pituitary Adenomas
Yu, R., Bonert, V. S., Saporta, I., Raffel, L. J., & Melmed, S. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1731 · Cited by 67
Clinical and Genetic Features of Familial Pituitary Adenomas
Daly, A., Jaffrain‐Rea, M., & Beckers, A. M. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870135 · Cited by 38
Self-citationStratakis, C. A., Matyakhina, L., Courkoutsakis, N. A., Patronas, N., Voutetakis, A., Stergiopoulos, S. G., Bossis, I., & Carney, J. A. (2004) · KARGER eBooks · doi:10.1159/000079049 · Cited by 19
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Pathogenesis of pituitary tumors
Melmed, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 466
Daly, A. F., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Self-citationBeckers, A., Aaltonen, L. A., Daly, A. F., & Karhu, A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1013 · Cited by 360
Self-citationEndocrine Disrupting Chemicals: Effects on Endocrine Glands
Lauretta, R., Sansone, A., Sansone, M., Romanelli, F., & Appetecchia, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00178 · Cited by 340
Metadata
- Authors
- Daly, A. F., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., Raverot, G., Barlier, A., De Herder, W., Penfornis, A., Ciccarelli, E., Estour, B., Lecomte, P., Gatta, B., Chabre, O., Sabaté, M. I., Bertagna, X., Garcia Basavilbaso, N., Stalldecker, G., Colao, A., Ferolla, P., Wémeau, J.-L., Caron, P., Sadoul, J.-L., Oneto, A., Archambeaud, F., Calender, A., Sinilnikova, O., Montañana, C. F., Cavagnini, F., Hana, V., Solano, A., Delettieres, D., Luccio-Camelo, D. C., Basso, A., Rohmer, V., Brue, T., Bours, V., Teh, B. T., & Beckers, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-05-01
- Volume
- 92
- Issue
- 5
- Pages
- 1891-1896
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1969529910
- Cited by
- 326
- References
- 17
- FWCI
- 21.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.